Purecircle Ltd (PCRTF) 4.6000 $PCRTF Global Market Study

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Purecircle Ltd (PCRTF) 4.6000 $PCRTF

Global Market Study on Stevia 2015: Beverages Will Remain the Dominant Application Segment Through 2020
M2 - Tue Nov 03, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/vbtkqp/global_market) has announced the addition of the "Global Market Study on Stevia: Beverages Will Remain the Dominant Application Segment Through 2020" report to their offering. The worth of the global stevia market was estimated to be US$ 347 million in 2014 and according to our market research, the market will witness a high single-digit CAGR through 2020 and reach a valuation of US$ 565.2 million. The key factors responsible for stevia's growth through 2020 include consumer awareness about the risk factors associated with high sugar consumption. Stevia's use as an ingredient was estimated to be 5,100.6 tonnes in 2014 and it is projected to reach 8.506.9 tonnes by 2020. Leading brands around the world are aware of the positive consumer sentiment about stevia, and they are widening their product offerings to cater to the demands of health-conscious consumers. Stevia is available in three forms, including liquid extract, powder extract and leaf. Among these, the demand for powder extract was the highest in 2014 and it is anticipated that the demand will continue to be robust through 2020. On the other hand, the liquid extract- and leaf- segment are anticipated to be worth US$ 112 million and US$ 85.6 million by 2020. Dominant application segments of stevia are beverages, table top sweeteners, and packaged food products. Among these, the beverage application segment was valued at US$ 120.4 Mn in 2014. According to our analysis, this application segment will witness a steady CAGR to reach a valuation of US$ 196.7 by 2020. On the other hand, table top sweetener segment, which was valued at US$ 68.8 million in 2014 is projected to witness a steady CAGR through 2020. Asia Pacific excluding Japan (APEJ) had the highest market share in 2014, accounting for over one-fourth of the market. According to our analysis, APEJ will continue to be a dominant region for the demand of stevia; however, it will lose its dominance to North America by 2020. The North American region had a share of 24% in the global stevia market in 2014. It is projected that North America will have the largest market share of 25.8% by 2020. Another key region for stevia market is Latin America. Demand for stevia-based products will ensure that stevia market expands at a steady rate in the region. Key Topics Covered: 1. Research Methodology 2. Assumptions & Acronyms Used 3. Global Stevia Market - Executive Summary 4. Global Stevia Market: Taxonomy 5. Global Sweetener Market Overview 6. Global Stevia Market Overview 7. Global Stevia Market Dynamics 8. Global Stevia Market Analysis & Forecast: By Extract Type 9. Global Stevia Market Analysis & Forecast By Application 10. Global Stevia Market Analysis & Forecast: By Geography 11. Global Stevia Market: Company Profiles - Cargill Inc. - Evolva Holding S.A. - GLG Life Tech Corp. - Ingredion Inc. - Nestl? S.A. - PepsiCo Inc. - PureCircle Ltd. - Stevia Corp. - Tate & Lyle Plc. - The Coca-Cola Company For more information visit http://www.researchandmarkets.com/research/vb...bal_market
PEP: 108.27 (+0.78)

Stevia Market: Global Industry Analysis and Opportunity Assessment 2014-2020
M2 - Fri Jun 05, 3:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2hz7gq/stevia_market) has announced the addition of the "Stevia Market: Global Industry Analysis and Opportunity Assessment 2014 - 2020" report to their offering. Globally, the sweetener market is estimated to be US$ 68.1 billion in 2014 and expected to reach at US$ 95.9 billion by 2020, registering a CAGR of 5.7% during 2014-2020 Whereas, stevia market is estimated to value at US$ 347.0 million in 2014 and expected to reach US$ 565.2 million by 2020, reflecting a CAGR of 8.5% during the forecast period. In terms of volume consumption of stevia it is expected to reach 8,506.9 tonnes by the end of 2020, registering an annual growth of around 7-8% during the forecast period. On the basis of extract type stevia market segmentation includes liquid, powder, and leaf extract. Liquid extracts are further sub-segmented as clear liquid extract and dark liquid extract. Also, powder stevia extracts are sub-segmented into stevia blends, sweet glycosides (40-50%) and sweet glycosides (80-95%). Among the various extract types, powder extracts contribution to the overall pie is expected to dominant during the forecast period, accounting for 65% of the overall stevia market share by 2020. However, liquid extracts segment is experiencing a robust CAGR of 8.7% during the forecast period. This growth is supported by extensive use of stevia liquid in direct consumption as table top sweetener coupled with assorted stevia-based liquid products globally. On the basis of application or use the stevia market include dairy food products, bakery products, dietary supplements, confectionery, table top sweeteners, beverages, packaged food products, snacks, and others. Among all these segments packaged food products, beverages and table top sweeteners are collectively expected to account for around 72.0% of the global stevia market. Geographically, the global stevia market analysis focusses on North America, Latin America, Eastern Europe, Western Europe, Japan, Asia Pacific Excluding Japan, Japan and Middle East and Africa (MEA). North America represents the most lucrative market, followed by Latin America and Asia Pacific Excluding Japan. North America is expected to register a CAGR of 9.8% accounting for US$ 146.0 million by 2020. In Asia Pacific, China and India owe a significant contribution to growth of Asia Pacific stevia market and thus, represent opportunities for manufacturers in the near future. MEA may represent as a potential market due to increasing disposable income and modern retail infrastructure during later years of forecast period i.e. 2018-2020. Japan records comparatively less growth. This is due to soaring prices of stevia coupled with increased exports of stevia from Japan to other. Companies Mentioned - Cargill Inc. - Evolva Holding S.A. - GLG Life Tech Corp. - Ingredion Inc. - Nestl? S.A. - PepsiCo Inc. - PureCircle Ltd. - Stevia Corp. - Tate & Lyle Plc. - The Coca-Cola Company For more information visit http://www.researchandmarkets.com/research/2h...via_market
PEP: 108.27 (+0.78)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 25

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading